MIT Technology Reviewnews

How AI helps scientists design the next generation of medicines

Thursday, July 23, 2026MIT Technology Review InsightsView original
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to…